NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

News and Updates

Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020

Call for applications for members of the European Commission expert group on Horizon Europe interim evaluation - deadline extended until 30 June

Published on | 1 year ago

Programmes Horizon Europe   Horizon 2020  

The European Commission’s Directorate-General Research and Innovation (DG RTD) has taken the initiative to set up the Commission Expert Group on the Interim Evaluation of Horizon Europe with a view to providing the Commission with recommendations for the future of the framework programme, based on the conclusions of the ex-post evaluation of Horizon 2020 and of the interim evaluation of Horizon Europe, in order to feed into the design of the next Framework Programme (2028-2034).

A call for applications for the selection of members of the European Commission expert group on the Interim Evaluation of Horizon Europe opened on 15 May and will close on 30 June.

The expert group shall consist of up to 15 members. A reserve list of suitable candidates that may be used to appoint replacements may be established.

Members shall be appointed for up to 16 months. The expert group shall meet six times in total on Commission premises or virtually. Members should be prepared to attend meetings, contribute actively to discussions, be involved in preparatory work ahead of meetings, to examine and provide comments on documents under discussion, and to act as 'rapporteurs' on an ad hoc basis.

Candidates should posess among others a proven and relevant competence and experience, including at European and/or international level, in areas relevant to the design, implementation and evaluation of Research and Innovation programmes and dispose of an expertise in one or more areas relevant to a component of Horizon Europe.

The application should include a cover letter, classification form, selection criteria form, CV and a declaration of interests form.

All information on the call for applications can be found in the announcement in the Register of Commission Expert Groups and Other Similar Entities

myOVERVIEW
- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1484 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.